Global Biologics Market Insight and Forecast to 2026
The research team projects that the Biologics market size will grow from XXX in 2019 to XXX by 2026, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2026.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
Eli Lilly & Company
Sanofi
Celltrion
Samsung Biologics
Abbvie Inc.
F Hoffman La Roche
Merck & Co. Inc.
Amgen
Addgene
Pfizer Inc.
Novo Nordisk A/S
Johnson & Johnson Services Inc.
By Type
Monoclonal Antibodies
Vaccines
Recombinant Proteins
Antisense
RNAi
By Application
Infectious Diseases
Oncology
Immunology
Autoimmune Diseases
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
South Asia
India
Southeast Asia
Indonesia
Thailand
Singapore
Middle East
Turkey
Saudi Arabia
Iran
Africa
Nigeria
South Africa
Oceania
Australia
South America
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Biologics 2015-2020, and development forecast 2021-2026 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2019.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2015-2020 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2021-2026. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Biologics Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the Biologics Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Biologics market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
Eli Lilly & Company
Sanofi
Celltrion
Samsung Biologics
Abbvie Inc.
F Hoffman La Roche
Merck & Co. Inc.
Amgen
Addgene
Pfizer Inc.
Novo Nordisk A/S
Johnson & Johnson Services Inc.
By Type
Monoclonal Antibodies
Vaccines
Recombinant Proteins
Antisense
RNAi
By Application
Infectious Diseases
Oncology
Immunology
Autoimmune Diseases
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
South Asia
India
Southeast Asia
Indonesia
Thailand
Singapore
Middle East
Turkey
Saudi Arabia
Iran
Africa
Nigeria
South Africa
Oceania
Australia
South America
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Biologics 2015-2020, and development forecast 2021-2026 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2019.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2015-2020 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2021-2026. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Biologics Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the Biologics Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Biologics market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biologics Revenue
1.4 Market Analysis by Type
1.4.1 Global Biologics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Monoclonal Antibodies
1.4.3 Vaccines
1.4.4 Recombinant Proteins
1.4.5 Antisense
1.4.6 RNAi
1.5 Market by Application
1.5.1 Global Biologics Market Share by Application: 2021-2026
1.5.2 Infectious Diseases
1.5.3 Oncology
1.5.4 Immunology
1.5.5 Autoimmune Diseases
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Biologics Market Perspective (2021-2026)
2.2 Biologics Growth Trends by Regions
2.2.1 Biologics Market Size by Regions: 2015 VS 2021 VS 2026
2.2.2 Biologics Historic Market Size by Regions (2015-2020)
2.2.3 Biologics Forecasted Market Size by Regions (2021-2026)
3 MARKET COMPETITION BY MANUFACTURERS
3.1 Global Biologics Production Capacity Market Share by Manufacturers (2015-2020)
3.2 Global Biologics Revenue Market Share by Manufacturers (2015-2020)
3.3 Global Biologics Average Price by Manufacturers (2015-2020)
4 BIOLOGICS PRODUCTION BY REGIONS
4.1 North America
4.1.1 North America Biologics Market Size (2015-2026)
4.1.2 Biologics Key Players in North America (2015-2020)
4.1.3 North America Biologics Market Size by Type (2015-2020)
4.1.4 North America Biologics Market Size by Application (2015-2020)
4.2 East Asia
4.2.1 East Asia Biologics Market Size (2015-2026)
4.2.2 Biologics Key Players in East Asia (2015-2020)
4.2.3 East Asia Biologics Market Size by Type (2015-2020)
4.2.4 East Asia Biologics Market Size by Application (2015-2020)
4.3 Europe
4.3.1 Europe Biologics Market Size (2015-2026)
4.3.2 Biologics Key Players in Europe (2015-2020)
4.3.3 Europe Biologics Market Size by Type (2015-2020)
4.3.4 Europe Biologics Market Size by Application (2015-2020)
4.4 South Asia
4.4.1 South Asia Biologics Market Size (2015-2026)
4.4.2 Biologics Key Players in South Asia (2015-2020)
4.4.3 South Asia Biologics Market Size by Type (2015-2020)
4.4.4 South Asia Biologics Market Size by Application (2015-2020)
4.5 Southeast Asia
4.5.1 Southeast Asia Biologics Market Size (2015-2026)
4.5.2 Biologics Key Players in Southeast Asia (2015-2020)
4.5.3 Southeast Asia Biologics Market Size by Type (2015-2020)
4.5.4 Southeast Asia Biologics Market Size by Application (2015-2020)
4.6 Middle East
4.6.1 Middle East Biologics Market Size (2015-2026)
4.6.2 Biologics Key Players in Middle East (2015-2020)
4.6.3 Middle East Biologics Market Size by Type (2015-2020)
4.6.4 Middle East Biologics Market Size by Application (2015-2020)
4.7 Africa
4.7.1 Africa Biologics Market Size (2015-2026)
4.7.2 Biologics Key Players in Africa (2015-2020)
4.7.3 Africa Biologics Market Size by Type (2015-2020)
4.7.4 Africa Biologics Market Size by Application (2015-2020)
4.8 Oceania
4.8.1 Oceania Biologics Market Size (2015-2026)
4.8.2 Biologics Key Players in Oceania (2015-2020)
4.8.3 Oceania Biologics Market Size by Type (2015-2020)
4.8.4 Oceania Biologics Market Size by Application (2015-2020)
4.9 South America
4.9.1 South America Biologics Market Size (2015-2026)
4.9.2 Biologics Key Players in South America (2015-2020)
4.9.3 South America Biologics Market Size by Type (2015-2020)
4.9.4 South America Biologics Market Size by Application (2015-2020)
4.10 Rest of the World
4.10.1 Rest of the World Biologics Market Size (2015-2026)
4.10.2 Biologics Key Players in Rest of the World (2015-2020)
4.10.3 Rest of the World Biologics Market Size by Type (2015-2020)
4.10.4 Rest of the World Biologics Market Size by Application (2015-2020)
5 BIOLOGICS CONSUMPTION BY REGION
5.1 North America
5.1.1 North America Biologics Consumption by Countries
5.1.2 United States
5.1.3 Canada
5.1.4 Mexico
5.2 East Asia
5.2.1 East Asia Biologics Consumption by Countries
5.2.2 China
5.2.3 Japan
5.2.4 South Korea
5.3 Europe
5.3.1 Europe Biologics Consumption by Countries
5.3.2 Germany
5.3.3 United Kingdom
5.3.4 France
5.3.5 Italy
5.3.6 Russia
5.3.7 Spain
5.3.8 Netherlands
5.3.9 Switzerland
5.3.10 Poland
5.4 South Asia
5.4.1 South Asia Biologics Consumption by Countries
5.4.2 India
5.4.3 Pakistan
5.4.4 Bangladesh
5.5 Southeast Asia
5.5.1 Southeast Asia Biologics Consumption by Countries
5.5.2 Indonesia
5.5.3 Thailand
5.5.4 Singapore
5.5.5 Malaysia
5.5.6 Philippines
5.5.7 Vietnam
5.5.8 Myanmar
5.6 Middle East
5.6.1 Middle East Biologics Consumption by Countries
5.6.2 Turkey
5.6.3 Saudi Arabia
5.6.4 Iran
5.6.5 United Arab Emirates
5.6.6 Israel
5.6.7 Iraq
5.6.8 Qatar
5.6.9 Kuwait
5.6.10 Oman
5.7 Africa
5.7.1 Africa Biologics Consumption by Countries
5.7.2 Nigeria
5.7.3 South Africa
5.7.4 Egypt
5.7.5 Algeria
5.7.6 Morocco
5.8 Oceania
5.8.1 Oceania Biologics Consumption by Countries
5.8.2 Australia
5.8.3 New Zealand
5.9 South America
5.9.1 South America Biologics Consumption by Countries
5.9.2 Brazil
5.9.3 Argentina
5.9.4 Columbia
5.9.5 Chile
5.9.6 Venezuela
5.9.7 Peru
5.9.8 Puerto Rico
5.9.9 Ecuador
5.10 Rest of the World
5.10.1 Rest of the World Biologics Consumption by Countries
5.10.2 Kazakhstan
6 BIOLOGICS SALES MARKET BY TYPE (2015-2026)
6.1 Global Biologics Historic Market Size by Type (2015-2020)
6.2 Global Biologics Forecasted Market Size by Type (2021-2026)
7 BIOLOGICS CONSUMPTION MARKET BY APPLICATION(2015-2026)
7.1 Global Biologics Historic Market Size by Application (2015-2020)
7.2 Global Biologics Forecasted Market Size by Application (2021-2026)
8 COMPANY PROFILES AND KEY FIGURES IN BIOLOGICS BUSINESS
8.1 Eli Lilly & Company
8.1.1 Eli Lilly & Company Company Profile
8.1.2 Eli Lilly & Company Biologics Product Specification
8.1.3 Eli Lilly & Company Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.2 Sanofi
8.2.1 Sanofi Company Profile
8.2.2 Sanofi Biologics Product Specification
8.2.3 Sanofi Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.3 Celltrion
8.3.1 Celltrion Company Profile
8.3.2 Celltrion Biologics Product Specification
8.3.3 Celltrion Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.4 Samsung Biologics
8.4.1 Samsung Biologics Company Profile
8.4.2 Samsung Biologics Biologics Product Specification
8.4.3 Samsung Biologics Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.5 Abbvie Inc.
8.5.1 Abbvie Inc. Company Profile
8.5.2 Abbvie Inc. Biologics Product Specification
8.5.3 Abbvie Inc. Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.6 F Hoffman La Roche
8.6.1 F Hoffman La Roche Company Profile
8.6.2 F Hoffman La Roche Biologics Product Specification
8.6.3 F Hoffman La Roche Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.7 Merck & Co. Inc.
8.7.1 Merck & Co. Inc. Company Profile
8.7.2 Merck & Co. Inc. Biologics Product Specification
8.7.3 Merck & Co. Inc. Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.8 Amgen
8.8.1 Amgen Company Profile
8.8.2 Amgen Biologics Product Specification
8.8.3 Amgen Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.9 Addgene
8.9.1 Addgene Company Profile
8.9.2 Addgene Biologics Product Specification
8.9.3 Addgene Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.10 Pfizer Inc.
8.10.1 Pfizer Inc. Company Profile
8.10.2 Pfizer Inc. Biologics Product Specification
8.10.3 Pfizer Inc. Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.11 Novo Nordisk A/S
8.11.1 Novo Nordisk A/S Company Profile
8.11.2 Novo Nordisk A/S Biologics Product Specification
8.11.3 Novo Nordisk A/S Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.12 Johnson & Johnson Services Inc.
8.12.1 Johnson & Johnson Services Inc. Company Profile
8.12.2 Johnson & Johnson Services Inc. Biologics Product Specification
8.12.3 Johnson & Johnson Services Inc. Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
9 PRODUCTION AND SUPPLY FORECAST
9.1 Global Forecasted Production of Biologics (2021-2026)
9.2 Global Forecasted Revenue of Biologics (2021-2026)
9.3 Global Forecasted Price of Biologics (2015-2026)
9.4 Global Forecasted Production of Biologics by Region (2021-2026)
9.4.1 North America Biologics Production, Revenue Forecast (2021-2026)
9.4.2 East Asia Biologics Production, Revenue Forecast (2021-2026)
9.4.3 Europe Biologics Production, Revenue Forecast (2021-2026)
9.4.4 South Asia Biologics Production, Revenue Forecast (2021-2026)
9.4.5 Southeast Asia Biologics Production, Revenue Forecast (2021-2026)
9.4.6 Middle East Biologics Production, Revenue Forecast (2021-2026)
9.4.7 Africa Biologics Production, Revenue Forecast (2021-2026)
9.4.8 Oceania Biologics Production, Revenue Forecast (2021-2026)
9.4.9 South America Biologics Production, Revenue Forecast (2021-2026)
9.4.10 Rest of the World Biologics Production, Revenue Forecast (2021-2026)
9.5 Forecast by Type and by Application (2021-2026)
9.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
9.5.2 Global Forecasted Consumption of Biologics by Application (2021-2026)
10 CONSUMPTION AND DEMAND FORECAST
10.1 North America Forecasted Consumption of Biologics by Country
10.2 East Asia Market Forecasted Consumption of Biologics by Country
10.3 Europe Market Forecasted Consumption of Biologics by Countriy
10.4 South Asia Forecasted Consumption of Biologics by Country
10.5 Southeast Asia Forecasted Consumption of Biologics by Country
10.6 Middle East Forecasted Consumption of Biologics by Country
10.7 Africa Forecasted Consumption of Biologics by Country
10.8 Oceania Forecasted Consumption of Biologics by Country
10.9 South America Forecasted Consumption of Biologics by Country
10.10 Rest of the world Forecasted Consumption of Biologics by Country
11 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
11.1 Marketing Channel
11.2 Biologics Distributors List
11.3 Biologics Customers
12 INDUSTRY TRENDS AND GROWTH STRATEGY
12.1 Market Top Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porter’s Five Forces Analysis
12.5 Biologics Market Growth Strategy
13 ANALYST'S VIEWPOINTS/CONCLUSIONS
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Disclaimer
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biologics Revenue
1.4 Market Analysis by Type
1.4.1 Global Biologics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Monoclonal Antibodies
1.4.3 Vaccines
1.4.4 Recombinant Proteins
1.4.5 Antisense
1.4.6 RNAi
1.5 Market by Application
1.5.1 Global Biologics Market Share by Application: 2021-2026
1.5.2 Infectious Diseases
1.5.3 Oncology
1.5.4 Immunology
1.5.5 Autoimmune Diseases
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Biologics Market Perspective (2021-2026)
2.2 Biologics Growth Trends by Regions
2.2.1 Biologics Market Size by Regions: 2015 VS 2021 VS 2026
2.2.2 Biologics Historic Market Size by Regions (2015-2020)
2.2.3 Biologics Forecasted Market Size by Regions (2021-2026)
3 MARKET COMPETITION BY MANUFACTURERS
3.1 Global Biologics Production Capacity Market Share by Manufacturers (2015-2020)
3.2 Global Biologics Revenue Market Share by Manufacturers (2015-2020)
3.3 Global Biologics Average Price by Manufacturers (2015-2020)
4 BIOLOGICS PRODUCTION BY REGIONS
4.1 North America
4.1.1 North America Biologics Market Size (2015-2026)
4.1.2 Biologics Key Players in North America (2015-2020)
4.1.3 North America Biologics Market Size by Type (2015-2020)
4.1.4 North America Biologics Market Size by Application (2015-2020)
4.2 East Asia
4.2.1 East Asia Biologics Market Size (2015-2026)
4.2.2 Biologics Key Players in East Asia (2015-2020)
4.2.3 East Asia Biologics Market Size by Type (2015-2020)
4.2.4 East Asia Biologics Market Size by Application (2015-2020)
4.3 Europe
4.3.1 Europe Biologics Market Size (2015-2026)
4.3.2 Biologics Key Players in Europe (2015-2020)
4.3.3 Europe Biologics Market Size by Type (2015-2020)
4.3.4 Europe Biologics Market Size by Application (2015-2020)
4.4 South Asia
4.4.1 South Asia Biologics Market Size (2015-2026)
4.4.2 Biologics Key Players in South Asia (2015-2020)
4.4.3 South Asia Biologics Market Size by Type (2015-2020)
4.4.4 South Asia Biologics Market Size by Application (2015-2020)
4.5 Southeast Asia
4.5.1 Southeast Asia Biologics Market Size (2015-2026)
4.5.2 Biologics Key Players in Southeast Asia (2015-2020)
4.5.3 Southeast Asia Biologics Market Size by Type (2015-2020)
4.5.4 Southeast Asia Biologics Market Size by Application (2015-2020)
4.6 Middle East
4.6.1 Middle East Biologics Market Size (2015-2026)
4.6.2 Biologics Key Players in Middle East (2015-2020)
4.6.3 Middle East Biologics Market Size by Type (2015-2020)
4.6.4 Middle East Biologics Market Size by Application (2015-2020)
4.7 Africa
4.7.1 Africa Biologics Market Size (2015-2026)
4.7.2 Biologics Key Players in Africa (2015-2020)
4.7.3 Africa Biologics Market Size by Type (2015-2020)
4.7.4 Africa Biologics Market Size by Application (2015-2020)
4.8 Oceania
4.8.1 Oceania Biologics Market Size (2015-2026)
4.8.2 Biologics Key Players in Oceania (2015-2020)
4.8.3 Oceania Biologics Market Size by Type (2015-2020)
4.8.4 Oceania Biologics Market Size by Application (2015-2020)
4.9 South America
4.9.1 South America Biologics Market Size (2015-2026)
4.9.2 Biologics Key Players in South America (2015-2020)
4.9.3 South America Biologics Market Size by Type (2015-2020)
4.9.4 South America Biologics Market Size by Application (2015-2020)
4.10 Rest of the World
4.10.1 Rest of the World Biologics Market Size (2015-2026)
4.10.2 Biologics Key Players in Rest of the World (2015-2020)
4.10.3 Rest of the World Biologics Market Size by Type (2015-2020)
4.10.4 Rest of the World Biologics Market Size by Application (2015-2020)
5 BIOLOGICS CONSUMPTION BY REGION
5.1 North America
5.1.1 North America Biologics Consumption by Countries
5.1.2 United States
5.1.3 Canada
5.1.4 Mexico
5.2 East Asia
5.2.1 East Asia Biologics Consumption by Countries
5.2.2 China
5.2.3 Japan
5.2.4 South Korea
5.3 Europe
5.3.1 Europe Biologics Consumption by Countries
5.3.2 Germany
5.3.3 United Kingdom
5.3.4 France
5.3.5 Italy
5.3.6 Russia
5.3.7 Spain
5.3.8 Netherlands
5.3.9 Switzerland
5.3.10 Poland
5.4 South Asia
5.4.1 South Asia Biologics Consumption by Countries
5.4.2 India
5.4.3 Pakistan
5.4.4 Bangladesh
5.5 Southeast Asia
5.5.1 Southeast Asia Biologics Consumption by Countries
5.5.2 Indonesia
5.5.3 Thailand
5.5.4 Singapore
5.5.5 Malaysia
5.5.6 Philippines
5.5.7 Vietnam
5.5.8 Myanmar
5.6 Middle East
5.6.1 Middle East Biologics Consumption by Countries
5.6.2 Turkey
5.6.3 Saudi Arabia
5.6.4 Iran
5.6.5 United Arab Emirates
5.6.6 Israel
5.6.7 Iraq
5.6.8 Qatar
5.6.9 Kuwait
5.6.10 Oman
5.7 Africa
5.7.1 Africa Biologics Consumption by Countries
5.7.2 Nigeria
5.7.3 South Africa
5.7.4 Egypt
5.7.5 Algeria
5.7.6 Morocco
5.8 Oceania
5.8.1 Oceania Biologics Consumption by Countries
5.8.2 Australia
5.8.3 New Zealand
5.9 South America
5.9.1 South America Biologics Consumption by Countries
5.9.2 Brazil
5.9.3 Argentina
5.9.4 Columbia
5.9.5 Chile
5.9.6 Venezuela
5.9.7 Peru
5.9.8 Puerto Rico
5.9.9 Ecuador
5.10 Rest of the World
5.10.1 Rest of the World Biologics Consumption by Countries
5.10.2 Kazakhstan
6 BIOLOGICS SALES MARKET BY TYPE (2015-2026)
6.1 Global Biologics Historic Market Size by Type (2015-2020)
6.2 Global Biologics Forecasted Market Size by Type (2021-2026)
7 BIOLOGICS CONSUMPTION MARKET BY APPLICATION(2015-2026)
7.1 Global Biologics Historic Market Size by Application (2015-2020)
7.2 Global Biologics Forecasted Market Size by Application (2021-2026)
8 COMPANY PROFILES AND KEY FIGURES IN BIOLOGICS BUSINESS
8.1 Eli Lilly & Company
8.1.1 Eli Lilly & Company Company Profile
8.1.2 Eli Lilly & Company Biologics Product Specification
8.1.3 Eli Lilly & Company Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.2 Sanofi
8.2.1 Sanofi Company Profile
8.2.2 Sanofi Biologics Product Specification
8.2.3 Sanofi Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.3 Celltrion
8.3.1 Celltrion Company Profile
8.3.2 Celltrion Biologics Product Specification
8.3.3 Celltrion Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.4 Samsung Biologics
8.4.1 Samsung Biologics Company Profile
8.4.2 Samsung Biologics Biologics Product Specification
8.4.3 Samsung Biologics Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.5 Abbvie Inc.
8.5.1 Abbvie Inc. Company Profile
8.5.2 Abbvie Inc. Biologics Product Specification
8.5.3 Abbvie Inc. Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.6 F Hoffman La Roche
8.6.1 F Hoffman La Roche Company Profile
8.6.2 F Hoffman La Roche Biologics Product Specification
8.6.3 F Hoffman La Roche Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.7 Merck & Co. Inc.
8.7.1 Merck & Co. Inc. Company Profile
8.7.2 Merck & Co. Inc. Biologics Product Specification
8.7.3 Merck & Co. Inc. Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.8 Amgen
8.8.1 Amgen Company Profile
8.8.2 Amgen Biologics Product Specification
8.8.3 Amgen Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.9 Addgene
8.9.1 Addgene Company Profile
8.9.2 Addgene Biologics Product Specification
8.9.3 Addgene Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.10 Pfizer Inc.
8.10.1 Pfizer Inc. Company Profile
8.10.2 Pfizer Inc. Biologics Product Specification
8.10.3 Pfizer Inc. Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.11 Novo Nordisk A/S
8.11.1 Novo Nordisk A/S Company Profile
8.11.2 Novo Nordisk A/S Biologics Product Specification
8.11.3 Novo Nordisk A/S Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
8.12 Johnson & Johnson Services Inc.
8.12.1 Johnson & Johnson Services Inc. Company Profile
8.12.2 Johnson & Johnson Services Inc. Biologics Product Specification
8.12.3 Johnson & Johnson Services Inc. Biologics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
9 PRODUCTION AND SUPPLY FORECAST
9.1 Global Forecasted Production of Biologics (2021-2026)
9.2 Global Forecasted Revenue of Biologics (2021-2026)
9.3 Global Forecasted Price of Biologics (2015-2026)
9.4 Global Forecasted Production of Biologics by Region (2021-2026)
9.4.1 North America Biologics Production, Revenue Forecast (2021-2026)
9.4.2 East Asia Biologics Production, Revenue Forecast (2021-2026)
9.4.3 Europe Biologics Production, Revenue Forecast (2021-2026)
9.4.4 South Asia Biologics Production, Revenue Forecast (2021-2026)
9.4.5 Southeast Asia Biologics Production, Revenue Forecast (2021-2026)
9.4.6 Middle East Biologics Production, Revenue Forecast (2021-2026)
9.4.7 Africa Biologics Production, Revenue Forecast (2021-2026)
9.4.8 Oceania Biologics Production, Revenue Forecast (2021-2026)
9.4.9 South America Biologics Production, Revenue Forecast (2021-2026)
9.4.10 Rest of the World Biologics Production, Revenue Forecast (2021-2026)
9.5 Forecast by Type and by Application (2021-2026)
9.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
9.5.2 Global Forecasted Consumption of Biologics by Application (2021-2026)
10 CONSUMPTION AND DEMAND FORECAST
10.1 North America Forecasted Consumption of Biologics by Country
10.2 East Asia Market Forecasted Consumption of Biologics by Country
10.3 Europe Market Forecasted Consumption of Biologics by Countriy
10.4 South Asia Forecasted Consumption of Biologics by Country
10.5 Southeast Asia Forecasted Consumption of Biologics by Country
10.6 Middle East Forecasted Consumption of Biologics by Country
10.7 Africa Forecasted Consumption of Biologics by Country
10.8 Oceania Forecasted Consumption of Biologics by Country
10.9 South America Forecasted Consumption of Biologics by Country
10.10 Rest of the world Forecasted Consumption of Biologics by Country
11 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
11.1 Marketing Channel
11.2 Biologics Distributors List
11.3 Biologics Customers
12 INDUSTRY TRENDS AND GROWTH STRATEGY
12.1 Market Top Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porter’s Five Forces Analysis
12.5 Biologics Market Growth Strategy
13 ANALYST'S VIEWPOINTS/CONCLUSIONS
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Disclaimer
LIST OF TABLES AND FIGURES
Table 1. Global Biologics Market Share by Type: 2020 VS 2026
Table 2. Monoclonal Antibodies Features
Table 3. Vaccines Features
Table 4. Recombinant Proteins Features
Table 5. Antisense Features
Table 6. RNAi Features
Table 11. Global Biologics Market Share by Application: 2020 VS 2026
Table 12. Infectious Diseases Case Studies
Table 13. Oncology Case Studies
Table 14. Immunology Case Studies
Table 15. Autoimmune Diseases Case Studies
Table 21. Commodity Prices-Metals Price Indices
Table 22. Commodity Prices- Precious Metal Price Indices
Table 23. Commodity Prices- Agricultural Raw Material Price Indices
Table 24. Commodity Prices- Food and Beverage Price Indices
Table 25. Commodity Prices- Fertilizer Price Indices
Table 26. Commodity Prices- Energy Price Indices
Table 27. G20+: Economic Policy Responses to COVID-19
Table 28. Biologics Report Years Considered
Table 29. Global Biologics Market Size YoY Growth 2021-2026 (US$ Million)
Table 30. Global Biologics Market Share by Regions: 2021 VS 2026
Table 31. North America Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 32. East Asia Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 33. Europe Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 34. South Asia Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 35. Southeast Asia Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 36. Middle East Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 37. Africa Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 38. Oceania Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 39. South America Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 40. Rest of the World Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 41. North America Biologics Consumption by Countries (2015-2020)
Table 42. East Asia Biologics Consumption by Countries (2015-2020)
Table 43. Europe Biologics Consumption by Region (2015-2020)
Table 44. South Asia Biologics Consumption by Countries (2015-2020)
Table 45. Southeast Asia Biologics Consumption by Countries (2015-2020)
Table 46. Middle East Biologics Consumption by Countries (2015-2020)
Table 47. Africa Biologics Consumption by Countries (2015-2020)
Table 48. Oceania Biologics Consumption by Countries (2015-2020)
Table 49. South America Biologics Consumption by Countries (2015-2020)
Table 50. Rest of the World Biologics Consumption by Countries (2015-2020)
Table 51. Eli Lilly & Company Biologics Product Specification
Table 52. Sanofi Biologics Product Specification
Table 53. Celltrion Biologics Product Specification
Table 54. Samsung Biologics Biologics Product Specification
Table 55. Abbvie Inc. Biologics Product Specification
Table 56. F Hoffman La Roche Biologics Product Specification
Table 57. Merck & Co. Inc. Biologics Product Specification
Table 58. Amgen Biologics Product Specification
Table 59. Addgene Biologics Product Specification
Table 60. Pfizer Inc. Biologics Product Specification
Table 61. Novo Nordisk A/S Biologics Product Specification
Table 62. Johnson & Johnson Services Inc. Biologics Product Specification
Table 101. Global Biologics Production Forecast by Region (2021-2026)
Table 102. Global Biologics Sales Volume Forecast by Type (2021-2026)
Table 103. Global Biologics Sales Volume Market Share Forecast by Type (2021-2026)
Table 104. Global Biologics Sales Revenue Forecast by Type (2021-2026)
Table 105. Global Biologics Sales Revenue Market Share Forecast by Type (2021-2026)
Table 106. Global Biologics Sales Price Forecast by Type (2021-2026)
Table 107. Global Biologics Consumption Volume Forecast by Application (2021-2026)
Table 108. Global Biologics Consumption Value Forecast by Application (2021-2026)
Table 109. North America Biologics Consumption Forecast 2021-2026 by Country
Table 110. East Asia Biologics Consumption Forecast 2021-2026 by Country
Table 111. Europe Biologics Consumption Forecast 2021-2026 by Country
Table 112. South Asia Biologics Consumption Forecast 2021-2026 by Country
Table 113. Southeast Asia Biologics Consumption Forecast 2021-2026 by Country
Table 114. Middle East Biologics Consumption Forecast 2021-2026 by Country
Table 115. Africa Biologics Consumption Forecast 2021-2026 by Country
Table 116. Oceania Biologics Consumption Forecast 2021-2026 by Country
Table 117. South America Biologics Consumption Forecast 2021-2026 by Country
Table 118. Rest of the world Biologics Consumption Forecast 2021-2026 by Country
Table 119. Biologics Distributors List
Table 120. Biologics Customers List
Table 121. Porter's Five Forces Analysis
Table 122. Key Executives Interviewed
Figure 1. North America Biologics Consumption and Growth Rate (2015-2020)
Figure 2. North America Biologics Consumption Market Share by Countries in 2020
Figure 3. United States Biologics Consumption and Growth Rate (2015-2020)
Figure 4. Canada Biologics Consumption and Growth Rate (2015-2020)
Figure 5. Mexico Biologics Consumption and Growth Rate (2015-2020)
Figure 6. East Asia Biologics Consumption and Growth Rate (2015-2020)
Figure 7. East Asia Biologics Consumption Market Share by Countries in 2020
Figure 8. China Biologics Consumption and Growth Rate (2015-2020)
Figure 9. Japan Biologics Consumption and Growth Rate (2015-2020)
Figure 10. South Korea Biologics Consumption and Growth Rate (2015-2020)
Figure 11. Europe Biologics Consumption and Growth Rate
Figure 12. Europe Biologics Consumption Market Share by Region in 2020
Figure 13. Germany Biologics Consumption and Growth Rate (2015-2020)
Figure 14. United Kingdom Biologics Consumption and Growth Rate (2015-2020)
Figure 15. France Biologics Consumption and Growth Rate (2015-2020)
Figure 16. Italy Biologics Consumption and Growth Rate (2015-2020)
Figure 17. Russia Biologics Consumption and Growth Rate (2015-2020)
Figure 18. Spain Biologics Consumption and Growth Rate (2015-2020)
Figure 19. Netherlands Biologics Consumption and Growth Rate (2015-2020)
Figure 20. Switzerland Biologics Consumption and Growth Rate (2015-2020)
Figure 21. Poland Biologics Consumption and Growth Rate (2015-2020)
Figure 22. South Asia Biologics Consumption and Growth Rate
Figure 23. South Asia Biologics Consumption Market Share by Countries in 2020
Figure 24. India Biologics Consumption and Growth Rate (2015-2020)
Figure 25. Pakistan Biologics Consumption and Growth Rate (2015-2020)
Figure 26. Bangladesh Biologics Consumption and Growth Rate (2015-2020)
Figure 27. Southeast Asia Biologics Consumption and Growth Rate
Figure 28. Southeast Asia Biologics Consumption Market Share by Countries in 2020
Figure 29. Indonesia Biologics Consumption and Growth Rate (2015-2020)
Figure 30. Thailand Biologics Consumption and Growth Rate (2015-2020)
Figure 31. Singapore Biologics Consumption and Growth Rate (2015-2020)
Figure 32. Malaysia Biologics Consumption and Growth Rate (2015-2020)
Figure 33. Philippines Biologics Consumption and Growth Rate (2015-2020)
Figure 34. Vietnam Biologics Consumption and Growth Rate (2015-2020)
Figure 35. Myanmar Biologics Consumption and Growth Rate (2015-2020)
Figure 36. Middle East Biologics Consumption and Growth Rate
Figure 37. Middle East Biologics Consumption Market Share by Countries in 2020
Figure 38. Turkey Biologics Consumption and Growth Rate (2015-2020)
Figure 39. Saudi Arabia Biologics Consumption and Growth Rate (2015-2020)
Figure 40. Iran Biologics Consumption and Growth Rate (2015-2020)
Figure 41. United Arab Emirates Biologics Consumption and Growth Rate (2015-2020)
Figure 42. Israel Biologics Consumption and Growth Rate (2015-2020)
Figure 43. Iraq Biologics Consumption and Growth Rate (2015-2020)
Figure 44. Qatar Biologics Consumption and Growth Rate (2015-2020)
Figure 45. Kuwait Biologics Consumption and Growth Rate (2015-2020)
Figure 46. Oman Biologics Consumption and Growth Rate (2015-2020)
Figure 47. Africa Biologics Consumption and Growth Rate
Figure 48. Africa Biologics Consumption Market Share by Countries in 2020
Figure 49. Nigeria Biologics Consumption and Growth Rate (2015-2020)
Figure 50. South Africa Biologics Consumption and Growth Rate (2015-2020)
Figure 51. Egypt Biologics Consumption and Growth Rate (2015-2020)
Figure 52. Algeria Biologics Consumption and Growth Rate (2015-2020)
Figure 53. Morocco Biologics Consumption and Growth Rate (2015-2020)
Figure 54. Oceania Biologics Consumption and Growth Rate
Figure 55. Oceania Biologics Consumption Market Share by Countries in 2020
Figure 56. Australia Biologics Consumption and Growth Rate (2015-2020)
Figure 57. New Zealand Biologics Consumption and Growth Rate (2015-2020)
Figure 58. South America Biologics Consumption and Growth Rate
Figure 59. South America Biologics Consumption Market Share by Countries in 2020
Figure 60. Brazil Biologics Consumption and Growth Rate (2015-2020)
Figure 61. Argentina Biologics Consumption and Growth Rate (2015-2020)
Figure 62. Columbia Biologics Consumption and Growth Rate (2015-2020)
Figure 63. Chile Biologics Consumption and Growth Rate (2015-2020)
Figure 64. Venezuelal Biologics Consumption and Growth Rate (2015-2020)
Figure 65. Peru Biologics Consumption and Growth Rate (2015-2020)
Figure 66. Puerto Rico Biologics Consumption and Growth Rate (2015-2020)
Figure 67. Ecuador Biologics Consumption and Growth Rate (2015-2020)
Figure 68. Rest of the World Biologics Consumption and Growth Rate
Figure 69. Rest of the World Biologics Consumption Market Share by Countries in 2020
Figure 70. Kazakhstan Biologics Consumption and Growth Rate (2015-2020)
Figure 71. Global Biologics Production Capacity Growth Rate Forecast (2021-2026)
Figure 72. Global Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 73. Global Biologics Price and Trend Forecast (2015-2026)
Figure 74. North America Biologics Production Growth Rate Forecast (2021-2026)
Figure 75. North America Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 76. East Asia Biologics Production Growth Rate Forecast (2021-2026)
Figure 77. East Asia Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 78. Europe Biologics Production Growth Rate Forecast (2021-2026)
Figure 79. Europe Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 80. South Asia Biologics Production Growth Rate Forecast (2021-2026)
Figure 81. South Asia Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 82. Southeast Asia Biologics Production Growth Rate Forecast (2021-2026)
Figure 83. Southeast Asia Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 84. Middle East Biologics Production Growth Rate Forecast (2021-2026)
Figure 85. Middle East Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 86. Africa Biologics Production Growth Rate Forecast (2021-2026)
Figure 87. Africa Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 88. Oceania Biologics Production Growth Rate Forecast (2021-2026)
Figure 89. Oceania Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 90. South America Biologics Production Growth Rate Forecast (2021-2026)
Figure 91. South America Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 92. Rest of the World Biologics Production Growth Rate Forecast (2021-2026)
Figure 93. Rest of the World Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 94. North America Biologics Consumption Forecast 2021-2026
Figure 95. East Asia Biologics Consumption Forecast 2021-2026
Figure 96. Europe Biologics Consumption Forecast 2021-2026
Figure 97. South Asia Biologics Consumption Forecast 2021-2026
Figure 98. Southeast Asia Biologics Consumption Forecast 2021-2026
Figure 99. Middle East Biologics Consumption Forecast 2021-2026
Figure 100. Africa Biologics Consumption Forecast 2021-2026
Figure 101. Oceania Biologics Consumption Forecast 2021-2026
Figure 102. South America Biologics Consumption Forecast 2021-2026
Figure 103. Rest of the world Biologics Consumption Forecast 2021-2026
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
Table 1. Global Biologics Market Share by Type: 2020 VS 2026
Table 2. Monoclonal Antibodies Features
Table 3. Vaccines Features
Table 4. Recombinant Proteins Features
Table 5. Antisense Features
Table 6. RNAi Features
Table 11. Global Biologics Market Share by Application: 2020 VS 2026
Table 12. Infectious Diseases Case Studies
Table 13. Oncology Case Studies
Table 14. Immunology Case Studies
Table 15. Autoimmune Diseases Case Studies
Table 21. Commodity Prices-Metals Price Indices
Table 22. Commodity Prices- Precious Metal Price Indices
Table 23. Commodity Prices- Agricultural Raw Material Price Indices
Table 24. Commodity Prices- Food and Beverage Price Indices
Table 25. Commodity Prices- Fertilizer Price Indices
Table 26. Commodity Prices- Energy Price Indices
Table 27. G20+: Economic Policy Responses to COVID-19
Table 28. Biologics Report Years Considered
Table 29. Global Biologics Market Size YoY Growth 2021-2026 (US$ Million)
Table 30. Global Biologics Market Share by Regions: 2021 VS 2026
Table 31. North America Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 32. East Asia Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 33. Europe Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 34. South Asia Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 35. Southeast Asia Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 36. Middle East Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 37. Africa Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 38. Oceania Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 39. South America Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 40. Rest of the World Biologics Market Size YoY Growth (2015-2026) (US$ Million)
Table 41. North America Biologics Consumption by Countries (2015-2020)
Table 42. East Asia Biologics Consumption by Countries (2015-2020)
Table 43. Europe Biologics Consumption by Region (2015-2020)
Table 44. South Asia Biologics Consumption by Countries (2015-2020)
Table 45. Southeast Asia Biologics Consumption by Countries (2015-2020)
Table 46. Middle East Biologics Consumption by Countries (2015-2020)
Table 47. Africa Biologics Consumption by Countries (2015-2020)
Table 48. Oceania Biologics Consumption by Countries (2015-2020)
Table 49. South America Biologics Consumption by Countries (2015-2020)
Table 50. Rest of the World Biologics Consumption by Countries (2015-2020)
Table 51. Eli Lilly & Company Biologics Product Specification
Table 52. Sanofi Biologics Product Specification
Table 53. Celltrion Biologics Product Specification
Table 54. Samsung Biologics Biologics Product Specification
Table 55. Abbvie Inc. Biologics Product Specification
Table 56. F Hoffman La Roche Biologics Product Specification
Table 57. Merck & Co. Inc. Biologics Product Specification
Table 58. Amgen Biologics Product Specification
Table 59. Addgene Biologics Product Specification
Table 60. Pfizer Inc. Biologics Product Specification
Table 61. Novo Nordisk A/S Biologics Product Specification
Table 62. Johnson & Johnson Services Inc. Biologics Product Specification
Table 101. Global Biologics Production Forecast by Region (2021-2026)
Table 102. Global Biologics Sales Volume Forecast by Type (2021-2026)
Table 103. Global Biologics Sales Volume Market Share Forecast by Type (2021-2026)
Table 104. Global Biologics Sales Revenue Forecast by Type (2021-2026)
Table 105. Global Biologics Sales Revenue Market Share Forecast by Type (2021-2026)
Table 106. Global Biologics Sales Price Forecast by Type (2021-2026)
Table 107. Global Biologics Consumption Volume Forecast by Application (2021-2026)
Table 108. Global Biologics Consumption Value Forecast by Application (2021-2026)
Table 109. North America Biologics Consumption Forecast 2021-2026 by Country
Table 110. East Asia Biologics Consumption Forecast 2021-2026 by Country
Table 111. Europe Biologics Consumption Forecast 2021-2026 by Country
Table 112. South Asia Biologics Consumption Forecast 2021-2026 by Country
Table 113. Southeast Asia Biologics Consumption Forecast 2021-2026 by Country
Table 114. Middle East Biologics Consumption Forecast 2021-2026 by Country
Table 115. Africa Biologics Consumption Forecast 2021-2026 by Country
Table 116. Oceania Biologics Consumption Forecast 2021-2026 by Country
Table 117. South America Biologics Consumption Forecast 2021-2026 by Country
Table 118. Rest of the world Biologics Consumption Forecast 2021-2026 by Country
Table 119. Biologics Distributors List
Table 120. Biologics Customers List
Table 121. Porter's Five Forces Analysis
Table 122. Key Executives Interviewed
Figure 1. North America Biologics Consumption and Growth Rate (2015-2020)
Figure 2. North America Biologics Consumption Market Share by Countries in 2020
Figure 3. United States Biologics Consumption and Growth Rate (2015-2020)
Figure 4. Canada Biologics Consumption and Growth Rate (2015-2020)
Figure 5. Mexico Biologics Consumption and Growth Rate (2015-2020)
Figure 6. East Asia Biologics Consumption and Growth Rate (2015-2020)
Figure 7. East Asia Biologics Consumption Market Share by Countries in 2020
Figure 8. China Biologics Consumption and Growth Rate (2015-2020)
Figure 9. Japan Biologics Consumption and Growth Rate (2015-2020)
Figure 10. South Korea Biologics Consumption and Growth Rate (2015-2020)
Figure 11. Europe Biologics Consumption and Growth Rate
Figure 12. Europe Biologics Consumption Market Share by Region in 2020
Figure 13. Germany Biologics Consumption and Growth Rate (2015-2020)
Figure 14. United Kingdom Biologics Consumption and Growth Rate (2015-2020)
Figure 15. France Biologics Consumption and Growth Rate (2015-2020)
Figure 16. Italy Biologics Consumption and Growth Rate (2015-2020)
Figure 17. Russia Biologics Consumption and Growth Rate (2015-2020)
Figure 18. Spain Biologics Consumption and Growth Rate (2015-2020)
Figure 19. Netherlands Biologics Consumption and Growth Rate (2015-2020)
Figure 20. Switzerland Biologics Consumption and Growth Rate (2015-2020)
Figure 21. Poland Biologics Consumption and Growth Rate (2015-2020)
Figure 22. South Asia Biologics Consumption and Growth Rate
Figure 23. South Asia Biologics Consumption Market Share by Countries in 2020
Figure 24. India Biologics Consumption and Growth Rate (2015-2020)
Figure 25. Pakistan Biologics Consumption and Growth Rate (2015-2020)
Figure 26. Bangladesh Biologics Consumption and Growth Rate (2015-2020)
Figure 27. Southeast Asia Biologics Consumption and Growth Rate
Figure 28. Southeast Asia Biologics Consumption Market Share by Countries in 2020
Figure 29. Indonesia Biologics Consumption and Growth Rate (2015-2020)
Figure 30. Thailand Biologics Consumption and Growth Rate (2015-2020)
Figure 31. Singapore Biologics Consumption and Growth Rate (2015-2020)
Figure 32. Malaysia Biologics Consumption and Growth Rate (2015-2020)
Figure 33. Philippines Biologics Consumption and Growth Rate (2015-2020)
Figure 34. Vietnam Biologics Consumption and Growth Rate (2015-2020)
Figure 35. Myanmar Biologics Consumption and Growth Rate (2015-2020)
Figure 36. Middle East Biologics Consumption and Growth Rate
Figure 37. Middle East Biologics Consumption Market Share by Countries in 2020
Figure 38. Turkey Biologics Consumption and Growth Rate (2015-2020)
Figure 39. Saudi Arabia Biologics Consumption and Growth Rate (2015-2020)
Figure 40. Iran Biologics Consumption and Growth Rate (2015-2020)
Figure 41. United Arab Emirates Biologics Consumption and Growth Rate (2015-2020)
Figure 42. Israel Biologics Consumption and Growth Rate (2015-2020)
Figure 43. Iraq Biologics Consumption and Growth Rate (2015-2020)
Figure 44. Qatar Biologics Consumption and Growth Rate (2015-2020)
Figure 45. Kuwait Biologics Consumption and Growth Rate (2015-2020)
Figure 46. Oman Biologics Consumption and Growth Rate (2015-2020)
Figure 47. Africa Biologics Consumption and Growth Rate
Figure 48. Africa Biologics Consumption Market Share by Countries in 2020
Figure 49. Nigeria Biologics Consumption and Growth Rate (2015-2020)
Figure 50. South Africa Biologics Consumption and Growth Rate (2015-2020)
Figure 51. Egypt Biologics Consumption and Growth Rate (2015-2020)
Figure 52. Algeria Biologics Consumption and Growth Rate (2015-2020)
Figure 53. Morocco Biologics Consumption and Growth Rate (2015-2020)
Figure 54. Oceania Biologics Consumption and Growth Rate
Figure 55. Oceania Biologics Consumption Market Share by Countries in 2020
Figure 56. Australia Biologics Consumption and Growth Rate (2015-2020)
Figure 57. New Zealand Biologics Consumption and Growth Rate (2015-2020)
Figure 58. South America Biologics Consumption and Growth Rate
Figure 59. South America Biologics Consumption Market Share by Countries in 2020
Figure 60. Brazil Biologics Consumption and Growth Rate (2015-2020)
Figure 61. Argentina Biologics Consumption and Growth Rate (2015-2020)
Figure 62. Columbia Biologics Consumption and Growth Rate (2015-2020)
Figure 63. Chile Biologics Consumption and Growth Rate (2015-2020)
Figure 64. Venezuelal Biologics Consumption and Growth Rate (2015-2020)
Figure 65. Peru Biologics Consumption and Growth Rate (2015-2020)
Figure 66. Puerto Rico Biologics Consumption and Growth Rate (2015-2020)
Figure 67. Ecuador Biologics Consumption and Growth Rate (2015-2020)
Figure 68. Rest of the World Biologics Consumption and Growth Rate
Figure 69. Rest of the World Biologics Consumption Market Share by Countries in 2020
Figure 70. Kazakhstan Biologics Consumption and Growth Rate (2015-2020)
Figure 71. Global Biologics Production Capacity Growth Rate Forecast (2021-2026)
Figure 72. Global Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 73. Global Biologics Price and Trend Forecast (2015-2026)
Figure 74. North America Biologics Production Growth Rate Forecast (2021-2026)
Figure 75. North America Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 76. East Asia Biologics Production Growth Rate Forecast (2021-2026)
Figure 77. East Asia Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 78. Europe Biologics Production Growth Rate Forecast (2021-2026)
Figure 79. Europe Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 80. South Asia Biologics Production Growth Rate Forecast (2021-2026)
Figure 81. South Asia Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 82. Southeast Asia Biologics Production Growth Rate Forecast (2021-2026)
Figure 83. Southeast Asia Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 84. Middle East Biologics Production Growth Rate Forecast (2021-2026)
Figure 85. Middle East Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 86. Africa Biologics Production Growth Rate Forecast (2021-2026)
Figure 87. Africa Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 88. Oceania Biologics Production Growth Rate Forecast (2021-2026)
Figure 89. Oceania Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 90. South America Biologics Production Growth Rate Forecast (2021-2026)
Figure 91. South America Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 92. Rest of the World Biologics Production Growth Rate Forecast (2021-2026)
Figure 93. Rest of the World Biologics Revenue Growth Rate Forecast (2021-2026)
Figure 94. North America Biologics Consumption Forecast 2021-2026
Figure 95. East Asia Biologics Consumption Forecast 2021-2026
Figure 96. Europe Biologics Consumption Forecast 2021-2026
Figure 97. South Asia Biologics Consumption Forecast 2021-2026
Figure 98. Southeast Asia Biologics Consumption Forecast 2021-2026
Figure 99. Middle East Biologics Consumption Forecast 2021-2026
Figure 100. Africa Biologics Consumption Forecast 2021-2026
Figure 101. Oceania Biologics Consumption Forecast 2021-2026
Figure 102. South America Biologics Consumption Forecast 2021-2026
Figure 103. Rest of the world Biologics Consumption Forecast 2021-2026
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
